698 results found

One particular example in this guidance was directed to a computer-implemented method of collecting digital images for training a neural network that is used for facial detection.

On December 7, 2018, Extang Corp. and Laurmark Enterprises, Inc. d/b/a BAK Industries—both of Ann Arbor, Michigan—filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.

The FDA has published a public notice requesting comments on the submission and listing of patent information.

Effective November 13th, all claims challenged in IPR, PGR, and CBM petitions will be interpreted under Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc).

Fourteen years ago, while discussing 35 USC 271(f) and related court precedents, I wrote that "a patentee can rely on its U.S. patent to seek damages for sales outside the U.S."

On May 18, 2022, the Commission issued an order instituting an advisory opinion proceeding in Certain High-Density Fiber Optic Equipment and Components Thereof (Inv. No. 337-TA-1194).

On November 4, 2021, Corning filed a complaint requesting institution of an enforcement proceeding to investigate alleged violations of the GEO and CDO by Panduit.

In BLUE GENTIAN, LLC v. TRISTAR PRODUCTS, INC., No. 2021-2316 (June 9, 2023) (Prost*, Chen, and Stark), a panel of the Court addressed the requirements for co-inventorship...

The collaboration and efficiency achieved by standards and the SDOs that create them advance the state of technology and business.

Following the Supreme Court's decision in U.S. v. Arthrex, the USPTO quickly established an interim Director review process by which the "[t]he Director [] may review final PTAB decisions and, upon review...

Design patents are very different from utility patents in that design patents only protect the ornamental features of an invention. In contrast to utility patents, the design is defined

The IPR program in general has been wildly successful in its intended purpose of providing a lower-cost alternative to patent litigation,...

In Rite-Hite v. Kelley Co., 56 F.3d 1538 (Fed. Cir. 1995) the Federal Circuit refused to award damages for the goods which were regularly sold as part of a package including patented goods.

Yesterday, in Biogen v. Mylan, the Federal Circuit ruled that claims in Biogen's U.S. patent 8,399,514 (the '514 patent) were invalid under 35 U.S.C. §112 for failing to satisfy the written description requirement.

The Commission determined to review in part the ID's finding of no violation as to the '531 and '819 patents.

On April 13, 2021, the ITC issued an advisory opinion in Certain Foam Footwear (Inv. No. 337-TA-567) finding that the new Original Beach DAWGS™ shoes made and imported into the U.S. by...

Patents are undoubtedly essential to many industries, and in recent years, the decisions regarding patent eligibility, written description, and enablement have certainly shaken up the life sciences industry in particular.